Published in Exp Hematol on May 01, 2009
Humanized culture medium for clinical expansion of human erythroblasts. Cell Transplant (2010) 1.07
β-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies. Haematologica (2015) 1.06
The dominant negative β isoform of the glucocorticoid receptor is uniquely expressed in erythroid cells expanded from polycythemia vera patients. Blood (2011) 0.92
Minireview: Nuclear receptors, hematopoiesis, and stem cells. Mol Endocrinol (2009) 0.87
Dexamethasone targeted directly to macrophages induces macrophage niches that promote erythroid expansion. Haematologica (2014) 0.85
The expression of the glucocorticoid receptor in human erythroblasts is uniquely regulated by KIT ligand: implications for stress erythropoiesis. Stem Cells Dev (2012) 0.83
Identification of a therapeutic dose of continuously delivered erythropoietin in the eye using an inducible promoter system. Curr Gene Ther (2013) 0.82
Glucocorticoid receptor localizes to adherens junctions at the plasma membrane of keratinocytes. PLoS One (2013) 0.78
Identification of NuRSERY, a new functional HDAC complex composed by HDAC5, GATA1, EKLF and pERK present in human erythroid cells. Int J Biochem Cell Biol (2014) 0.77
Chronic psychological stress activates BMP4-dependent extramedullary erythropoiesis. J Cell Mol Med (2013) 0.77
The role of glucocorticoid receptor (GR) polymorphisms in human erythropoiesis. Am J Blood Res (2014) 0.75
JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell (1993) 6.04
Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice. J Exp Med (2002) 3.24
Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood (2005) 3.10
The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. Mol Cell (2001) 2.10
Regulation of the erythropoietin gene. Blood (1999) 2.10
Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis. J Exp Med (2004) 1.98
GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant. J Exp Med (2003) 1.96
The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev (1999) 1.92
Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2. J Clin Invest (2008) 1.89
The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood (1999) 1.87
Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog Horm Res (2004) 1.82
The Erythropoietin Receptor: Structure, Activation and Intracellular Signal Transduction. Trends Endocrinol Metab (1999) 1.79
In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients. Blood Cells Mol Dis (2002) 1.70
Dynamics of GATA transcription factor expression during erythroid differentiation. Blood (1993) 1.69
Polymorphisms of the glucocorticoid receptor gene and major depression. Biol Psychiatry (2006) 1.62
Both proteasomes and lysosomes degrade the activated erythropoietin receptor. Blood (2004) 1.60
Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. Nature (2006) 1.59
Minireview: rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology (2006) 1.58
Interaction of the erythropoietin and stem-cell-factor receptors. Nature (1995) 1.55
Human erythropoietin receptor: cloning, expression, and biologic characterization. Blood (1990) 1.55
Polycythemia as the first manifestation of Cushing's disease. J Endocrinol Invest (2006) 1.54
Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their GATA-1 expression (GATA-1(low) mice). Blood (2001) 1.51
Reconstitution of the steroid receptor.hsp90 heterocomplex assembly system of rabbit reticulocyte lysate. J Biol Chem (1996) 1.50
Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Mol Cell Biol (1994) 1.47
Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expression. Genes Dev (2007) 1.45
Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality. Blood (2002) 1.44
Active conformation of the erythropoietin receptor: random and cysteine-scanning mutagenesis of the extracellular juxtamembrane and transmembrane domains. J Biol Chem (2006) 1.37
Potentiation of erythropoiesis in vitro by dexamethasone. J Clin Invest (1976) 1.29
Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7. Blood (1993) 1.25
Erythroid progenitor renewal versus differentiation: genetic evidence for cell autonomous, essential functions of EpoR, Stat5 and the GR. Oncogene (2006) 1.22
Glucocorticoid receptor isoforms generate transcription specificity. Trends Cell Biol (2006) 1.22
Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo. Mol Med (2006) 1.21
The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor. Blood (1997) 1.18
Acetylation and MAPK phosphorylation cooperate to regulate the degradation of active GATA-1. EMBO J (2006) 1.16
Glucocorticoid modulation of cytokine signaling. Tissue Antigens (2006) 1.15
Corticosteroid receptor genetic polymorphisms and stress responsivity. Endocrine (2005) 1.12
Long-term generation of colony-forming cells in liquid culture of CD34+ cord blood cells in the presence of recombinant human stem cell factor. Blood (1992) 1.03
Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. Am J Pathol (1999) 1.02
Thyroid hormones stimulate erythropoiesis in vitro. Br J Haematol (1977) 1.02
Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation. Mol Endocrinol (1993) 0.99
Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia. Leukemia (2001) 0.98
Potentiation of human erythropoiesis in vitro by thyroid hormone. Nature (1978) 0.93
A constitutively activated erythropoietin receptor stimulates proliferation and contributes to transformation of multipotent, committed nonerythroid and erythroid progenitor cells. Mol Cell Biol (1994) 0.92
Steroids and hematopoiesis. III. The response of granulocytic and erythroid colony-forming cells to steroids of different classes. Blood (1976) 0.90
Stem cell factor induces proliferation and differentiation of fetal progenitor cells in the mouse. Br J Haematol (1998) 0.89
Erythropoietin for end-stage renal disease. N Engl J Med (1998) 0.84
Understanding stress through the genome. Stress (2006) 0.83
Cytoskeletal and cell contact control of the glucocorticoid pathway. Mol Cell Endocrinol (2006) 0.81
The biology and clinical applications of recombinant erythropoietin. Semin Oncol (1998) 0.80
Interleukin-3 and erythropoietin cooperate in the regulation of the expression of erythroid-specific transcription factors during erythroid differentiation. Exp Hematol (2007) 0.79
Protein kinase Calpha is differentially activated during neonatal and adult erythropoiesis and favors expression of a reporter gene under the control of the (A)gamma globin-promoter in cellular models of hemoglobin switching. J Cell Biochem (2007) 0.77
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia. J Exp Med (2008) 3.24
Challenges and successes in developing new therapies for hepatitis C. Nature (2005) 3.22
Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice). Blood (2002) 3.06
Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs. J Biol Chem (2003) 2.72
Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase. J Virol (2003) 2.63
In vitro selection and characterization of hepatitis C virus serine protease variants resistant to an active-site peptide inhibitor. J Virol (2003) 2.55
Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons. Virology (2002) 2.49
Challenges with advanced therapy medicinal products and how to meet them. Nat Rev Drug Discov (2010) 2.09
GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant. J Exp Med (2003) 1.96
A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties. Antimicrob Agents Chemother (2004) 1.94
Characterization of the inhibition of hepatitis C virus RNA replication by nonnucleosides. J Virol (2004) 1.71
In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients. Blood Cells Mol Dis (2002) 1.70
Interdomain communication in hepatitis C virus polymerase abolished by small molecule inhibitors bound to a novel allosteric site. J Biol Chem (2005) 1.54
Pericyte coverage of abnormal blood vessels in myelofibrotic bone marrows. Haematologica (2007) 1.51
Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antiviral Res (2003) 1.50
Functional tricuspid regurgitation: an underestimated issue. Int J Cardiol (2013) 1.45
Selective expression of type I IFN genes in human dendritic cells infected with Mycobacterium tuberculosis. J Immunol (2002) 1.42
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1). Stem Cells (2006) 1.41
Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis. Blood (2002) 1.30
Erythroid cells in vitro: from developmental biology to blood transfusion products. Curr Opin Hematol (2009) 1.20
Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors. J Exp Med (2002) 1.19
Increased and pathologic emperipolesis of neutrophils within megakaryocytes associated with marrow fibrosis in GATA-1(low) mice. Blood (2004) 1.15
The effect of physical exercise on endothelial function. Sports Med (2009) 1.15
The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor. Blood (2006) 1.13
IFN regulatory factor-1 negatively regulates CD4+ CD25+ regulatory T cell differentiation by repressing Foxp3 expression. J Immunol (2008) 1.12
IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer. J Virol (2008) 1.10
Humanized culture medium for clinical expansion of human erythroblasts. Cell Transplant (2010) 1.07
A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-beta1 in the development of myelofibrosis. Blood (2005) 1.06
Pathological interactions between hematopoietic stem cells and their niche revealed by mouse models of primary myelofibrosis. Expert Rev Hematol (2009) 1.06
Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis. Am J Pathol (2005) 1.05
Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease. Exp Hematol (2008) 1.02
Tumor necrosis factor alpha (TNF-alpha) activates Jak1/Stat3-Stat5B signaling through TNFR-1 in human B cells. Cell Growth Differ (2002) 1.02
Potent inhibitors of subgenomic hepatitis C virus RNA replication through optimization of indole-N-acetamide allosteric inhibitors of the viral NS5B polymerase. J Med Chem (2005) 1.01
A requirement for NF-kappaB induction in the production of replication-competent HHV-8 virions. Oncogene (2004) 1.01
Role of acetylases and deacetylase inhibitors in IRF-1-mediated HIV-1 long terminal repeat transcription. Ann N Y Acad Sci (2004) 1.00
Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis. Blood (2013) 0.99
IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment. Neoplasia (2012) 0.99
Erythroblast enucleation. Haematologica (2010) 0.99
Identification of a key determinant of hepatitis C virus cell culture adaptation in domain II of NS3 helicase. J Biol Chem (2003) 0.98
Identification of two new synthetic histone deacetylase inhibitors that modulate globin gene expression in erythroid cells from healthy donors and patients with thalassemia. Mol Pharmacol (2007) 0.97
Intracellular HIV-1 Tat protein represses constitutive LMP2 transcription increasing proteasome activity by interfering with the binding of IRF-1 to STAT1. Biochem J (2006) 0.97
Modified apoptotic molecule (BID) reduces hepatitis C virus infection in mice with chimeric human livers. Nat Biotechnol (2003) 0.96
HCV antiviral resistance: the impact of in vitro studies on the development of antiviral agents targeting the viral NS5B polymerase. Antivir Chem Chemother (2005) 0.96
Development and preliminary optimization of indole-N-acetamide inhibitors of hepatitis C virus NS5B polymerase. J Med Chem (2005) 0.96
NF-E2 overexpression delays erythroid maturation and increases erythrocyte production. Br J Haematol (2009) 0.95
Concise review: stem cell-derived erythrocytes as upcoming players in blood transfusion. Stem Cells (2012) 0.94
Synthesis and SAR of piperazinyl-N-phenylbenzamides as inhibitors of hepatitis C virus RNA replication in cell culture. Bioorg Med Chem Lett (2009) 0.94
Therapeutics for HIV-1 reactivation from latency. Curr Opin Virol (2013) 0.93
Salivary chromogranin A, but not α-amylase, correlates with cardiovascular parameters during high-intensity exercise. Clin Endocrinol (Oxf) (2011) 0.93
The dominant negative β isoform of the glucocorticoid receptor is uniquely expressed in erythroid cells expanded from polycythemia vera patients. Blood (2011) 0.92
Variegation of the phenotype induced by the Gata1low mutation in mice of different genetic backgrounds. Blood (2005) 0.91
Repression of interferon regulatory factor 1 by hepatitis C virus core protein results in inhibition of antiviral and immunomodulatory genes. J Virol (2006) 0.90
Influenza vaccination among healthcare workers in Italy. Hum Vaccin Immunother (2014) 0.89
Phlebitis risk varies by peripheral venous catheter site and increases after 96 hours: a large multi-centre prospective study. J Adv Nurs (2014) 0.89
Identification and biological evaluation of a series of 1H-benzo[de]isoquinoline-1,3(2H)-diones as hepatitis C virus NS5B polymerase inhibitors. J Med Chem (2009) 0.89
Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase. J Biol Chem (2011) 0.88
Translational research on advanced therapies. Ann Ist Super Sanita (2011) 0.88
Differential amplification of murine bipotent megakaryocytic/erythroid progenitor and precursor cells during recovery from acute and chronic erythroid stress. Stem Cells (2005) 0.88
Gata1 expression driven by the alternative HS2 enhancer in the spleen rescues the hematopoietic failure induced by the hypomorphic Gata1low mutation. Blood (2009) 0.87
Multicentric cohort study on the long-term efficacy and safety of electronic cigarettes: study design and methodology. BMC Public Health (2013) 0.87
Role of Ets-1 in erythroid differentiation. Blood Cells Mol Dis (2003) 0.87
HIV-1, interferon and the interferon regulatory factor system: an interplay between induction, antiviral responses and viral evasion. Cytokine Growth Factor Rev (2012) 0.86
Role of Ets-1 in transcriptional regulation of transferrin receptor and erythroid differentiation. Oncogene (2002) 0.86
Structural basis for resistance of the genotype 2b hepatitis C virus NS5B polymerase to site A non-nucleoside inhibitors. J Mol Biol (2009) 0.86
Expression of signal transduction proteins during the differentiation of primary human erythroblasts. J Cell Physiol (2005) 0.86
EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors. PLoS One (2010) 0.85
Under HEMA conditions, self-replication of human erythroblasts is limited by autophagic death. Blood Cells Mol Dis (2011) 0.85
Critical role of IRF-8 in negative regulation of TLR3 expression by Src homology 2 domain-containing protein tyrosine phosphatase-2 activity in human myeloid dendritic cells. J Immunol (2011) 0.85
Inhibitory effect of 2'-substituted nucleosides on hepatitis C virus replication correlates with metabolic properties in replicon cells. Antimicrob Agents Chemother (2005) 0.84
Functional mitral regurgitation: from normal to pathological anatomy of mitral valve. Int J Cardiol (2011) 0.84
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: results from an observational prospective study in elective surgery. Am J Infect Control (2012) 0.83
The expression of the glucocorticoid receptor in human erythroblasts is uniquely regulated by KIT ligand: implications for stress erythropoiesis. Stem Cells Dev (2012) 0.83
The development of immune-modulating compounds to disrupt HIV latency. Cytokine Growth Factor Rev (2012) 0.83
Reporter substrates for assessing the activity of the hepatitis C virus NS3-4A serine protease in living cells. Anal Biochem (2004) 0.83
Recovery and Biodistribution of Ex Vivo Expanded Human Erythroblasts Injected into NOD/SCID/IL2Rγ mice. Stem Cells Int (2011) 0.82
EATRIS, a European initiative to boost translational biomedical research. Am J Nucl Med Mol Imaging (2013) 0.82
IRF-7: new role in the regulation of genes involved in adaptive immunity. Ann N Y Acad Sci (2007) 0.82
Phenotypic definition of the progenitor cells with erythroid differentiation potential present in human adult blood. Stem Cells Int (2011) 0.82
Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination. J Cell Physiol (2010) 0.82
An integrated approach identifies IFN-regulated microRNAs and targeted mRNAs modulated by different HCV replicon clones. BMC Genomics (2011) 0.82